Scaling down biopharmaceutical operations Part I: Fermentation

Pharmaceutical Technology Europe

Volumn 18, Issue 4, 2006, Pages 51-57

  Rathore, Anurag ^a   Krishnan, Raj ^a   Tozer, Stephanie ^a   Smiley, Dave ^a   Rausch, Steve ^a   Seely, Jim ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISSOLVED OXYGEN;

ARTICLE; BIOMASS; CONTROL SYSTEM; DRUG APPROVAL; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RESEARCH; DRUG STABILITY; FERMENTATION; GOOD MANUFACTURING PRACTICE; MOLECULAR WEIGHT; OPTICAL DENSITY; VALIDATION PROCESS;

EID: 33645742871     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. M.E. Dahlgren et al., Biotechnol. Prog. 9, 580-586 (1993).
2. T. Reynolds et al., Biotech. Bioeng. 83, 454-464 (2003).
3. E.G. Varga, N.J. Titchener-Hooker and P. Dunhill, Biotechnol. Bioeng. 74, 97-107 (2001).
4. R. Godavarti et al., "Scale-down models for purification processes: Approaches and applications," in A.S. Rathore and G. Sofer, Eds., Process Validation in Manufacturing of Biopharmaceuticals (Marcel Dekker, New York, NY, USA, 2005).